Trials / Unknown
UnknownNCT01049256
The Cyclocapnic Method for Measurement of Chemosensitivity
Developing an Improved Measure of Chemosensitivity for the Study of Periodic Breathing in Heart Failure: the Cyclocapnic Method
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- Male
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
We aim to test our method for measuring chemosensitivity (the ventilatory response to a change in carbon dioxide), which uses sinusoidal carbon dioxide stimuli. Hypotheses: * Carbon dioxide sensitivity is dependent on the cycle time over which we administer the gas (frequency). * Chemoreflex gain decreases as deadspace increases.
Detailed description
We will apply a new method for the measurement of chemosensitivity (how sensitive a person is to changes in carbon dioxide), which is one of the principle determinants of whether people with heart failure develop abnormal breathing patterns We have shown in a pilot study that administering sinusoidal patterns of inspired carbon dioxide produces similar sinusoidal responses in ventilation. We aim to test our method for measuring chemosensitivity, which uses sinusoidal carbon dioxide stimuli (similar to those that drive the oscillations in ventilation found in periodic breathing). We aim to show that how the cycle time of carbon dioxide administered affects the resulting ventilatory oscillations and therefore that when measuring the chemoreflex clinically, it is important to deliver carbon dioxide stimuli that replicate the cycle time of oscillations in carbon dioxide seen in periodic breathing (typically approximately one minute).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | carbon dioxide | sinusoidal carbon dioxide administration |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2010-04-01
- Completion
- 2010-10-01
- First posted
- 2010-01-14
- Last updated
- 2010-01-14
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01049256. Inclusion in this directory is not an endorsement.